Dr. Carmine Finelli is a distinguished researcher and clinician at Hospital “A. Maresca”–ASL Naples 3 Sud in Torre del Greco, Italy 
. With a notable career in medical research and healthcare, Dr. Finelli has significantly contributed to various areas of medical science 
.
Publication Profile:
Scopus
Education and Experience:
Dr. Finelli’s academic journey includes extensive training in medical science 
. He has worked in multiple prestigious institutions and gained invaluable experience in both clinical and research settings, focusing on improving patient outcomes and advancing medical knowledge 
.
Professional Development:
Throughout his career, Dr. Finelli has continually engaged in professional development 
. He has attended numerous conferences, workshops, and seminars, ensuring his skills and knowledge remain at the forefront of medical advancements 
.
Research Focus:
Dr. Finelli’s research focuses on the interplay between metabolic disorders, obesity, and related diseases 
. His work explores innovative approaches to treatment and prevention, particularly in relation to non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome 
.
Publications:
- “Reduced Pharmacological Intervention of Prehospital Services for Acute Alcohol Intoxication during the COVID-19 Pandemic in A Large District of Southern Italy” (2024)
- “Molecular Mechanisms and Mediators of Hepatotoxicity Resulting from an Excess of Lipids and Non-Alcoholic Fatty Liver Disease” (2023)
- “Acute alcohol intoxication across different age groups in 2014–2018: Prehospital care and biochemical correlates at a large University Hospital in southern Italy” (2022)
- “Metabolic Syndrome, Alzheimer’s Disease, and Covid 19: A Possible Correlation” (2021)
- “Obesity, COVID-19 and immunotherapy: The complex relationship!” (2020)
- “Obesity and immunotherapy: The surprisingly positive association!” (2020)
- “Obesity and adenovirus 36: A possible correlation?” (2020)
- “Characterization of Student Drinking Behaviors at the Beginning of the First Academic Year at One University in Southern Italy” (2019)
- “Contribution to molecular nutrition: Carbohydrates” (2019)
- “Corrigendum to ‘Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes’ (Oxidative Medicine and Cellular Longevity (2014)” (2018)